DISCOVERIES REPORTS (ISSN 2393249X), 2020, volume 3

CITATION: 

Alotaibi M, Ramzan K, Afzal S, Albadawi AA, Adib Adi HM, Ghareeb E. Reversible mitochondrial infantile liver failure with hemophagocytic lymphohistiocytosis associated with a TRMU gene mutation. Discoveries Reports 2020; 3: e7. DOI: 10.15190/drep.2020.1

 Submitted: April 22, 2020; Revised: May 11, 2020; Accepted: May 12, 2020; Published May 23, 2020;

 GO BACK to 2020, VOLUME 3

 GO BACK to DISCOVERIES REPORTS

Reversible mitochondrial infantile liver failure with hemophagocytic lymphohistiocytosis associated with a TRMU gene mutation 

Maha Alotaibi (1,#,*), Khushnooda Ramzan (2,#), Sibtain Afzal (3), Ahmad-A.Albadawi (4), Hala M. Adib Adi (5), Eatedal Ghareeb (6)

(1) Department of Genetics and Metabolism, King Saud Medical City, Riyadh, Saudi Arabia

(2) Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

(3) Faculty of Allied and Health Sciences, Imperial College of Business Studies, Lahore, Pakistan

(4) Lab Specialist, Saudi Molecular Diagnostics Laboratories, King Faisal Specialist Hospital International Company, Riyadh, Saudi Arabia

(5) King Saud Medical City Laboratories, Hematology Dept., King Saud Medical City, Riyadh, Saudi Arabia

(6) Department of Hematology and Oncology, King Saud Medical City, Riyadh, Saudi Arabia

# First two authors contributed equally to this work.

*Correspondence to: Dr. Maha Alotaibi, Department of Genetics and Metabolism, King Saud Medical City, Riyadh, Saudi Arabia; Email: maotaibi@ksmc.med.sa

Abstract

Mitochondrial diseases are a clinically heterogeneous group of multisystem disorders caused by mitochondrial dysfunction. Hepatic involvement is a common feature in neonatal mitochondrial hepatopathies, which may manifest as acute liver failure, hepatic steatohepatitis, cholestasis, or even as chronic liver failure of insidious onset. Mitochondrial diseases are usually severe and rapidly progressive conditions and eventually fatal. However, some of the rare forms show remarkable spontaneous recoveries. The diagnostic process is complex, requiring clinical, biochemical, histological, and genetic investigations. Mutations in several mitochondrial DNA (mt-DNA) and nuclear genes involved in mt-DNA stability and mitochondrial protein synthesis machinery have been associated with mitochondrial disorders. Recently, mutations of TRMU gene encoding mitochondrial tRNA-specific 2-thiouridylase defines the pathomechanism of mitochondrial protein translation defect in the neonatal period presenting with early-onset, reversible liver disease. Here, we report the clinical, biochemical, and genetic findings from one Arab Yamani child presenting with hepatopathy, hyperlactatemia and respiratory chain defect associated with hemophagocytic lymphohistiocytosis, a feature which has not been described in previously reported cases. The aim was to have a prompt definitive genetic diagnosis to provide timely clinical management, decrease morbidity, and improve the survival of the patient. Utilizing next-generation sequencing techniques we identified the pathogenic biallelic mutation c.835G>A (p.Val279Met) in TRMU gene by whole exome sequencing. Since spontaneous recovery is a rare feature in mitochondrial liver disorders, early identification of underlying TRMU mutation can influence clinical management decisions. Our results add to the repertoire of a small number of cases with TRMU mutations reported in mitochondrial liver diseases, for further elaboration of genotype-phenotype correlation.

Access full text of the manuscript here: Full text (pdf)

References

1. Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, Chinnery PF, Turnbull DM. Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2008;63:35-9.

2. Greaves LC, Reeve AK, Taylor RW, Turnbull DM. Mitochondrial DNA and disease. J Pathol. 2012;226:274-86.

3. García-Cazorla A, De Lonlay P, Nassogne MC, Rustin P, Touati G, Saudubray JM. Long-term follow-up of neonatal mitochondrial cytopathies: a study of 57 patients. Pediatrics (2005) 116:1170-7.

4. Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241:236–250.

5. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001;29:337-41.

6. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol. 2004;55:706-712.

7. Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D'Adamo P, Calvo S, Marsano RM, Donnini C, Weiher H, Strisciuglio P, Parini R, Sarzi E, Chan A, DiMauro S, Rötig A, Gasparini P, Ferrero I, Mootha VK, Tiranti V, Zeviani M. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006;38:570-5.

8. Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, Giordano I, Meznaric-Petrusa M, Baruffini E, Ferrero I, Zeviani M.Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis. 2009;32:143-58.

9. Sarzi E, Goffart S, Serre V, Chrétien D, Slama A, Munnich A, Spelbrink JN, Rötig A Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol. 2007;62:579-87.

10. Coenen MJ, Antonicka H, Ugalde C, Sasarman F, Rossi R, Heister JG, Newbold RF, Trijbels FJ, van den Heuvel LP, Shoubridge EA, Smeitink JA. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med. 2004;351:2080-6.

11. Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, Donnini C et al. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet. 2007 Jan;80(1):44-58.

12. Zeharia A, Shaag A, Pappo O, Mager-Heckel AM, Saada A, Beinat M, et al. Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet. 2009;85:401-7.

13. Boczonadi V, Bansagi B, Horvath R. Reversible infantile mitochondrial diseases. J Inherit Metab Dis. 2015;38:427-35.

14. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-24.

15. Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinf. 2010;11:548.

16. Kohda M, Tokuzawa Y, Kishita Y, Nyuzuki H, Moriyama Y, Mizuno Y et al. A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies. PLoS Genet. 2016;12:e1005679.

17. Levinger L, Mörl M, Florentz C. Mitochondrial tRNA 3' end metabolism and human disease. Nucleic Acids Res. 2004;32:5430-41.

18. Hagervall T, Edmonds C, McCloskey J, Bjork G. Transfer RNA(5-methylaminomethyl-2-thiouridine)-methyltransferase from Escherichia coli K-12 has two enzymatic activities. J Biol Chem. 1987;262:8488-95.

19. Umeda N, Suzuki T, Yukawa M, Ohya Y, Shindo H, Watanabe K, Suzuki T. Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J Biol Chem. 2005;280:1613-24.

20. Yan Q, Bykhovskaya Y, Li R, Mengesha E, Shohat M, Estivill X, Fischel-Ghodsian N, Guan MX. Human TRMU encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase is a putative nuclear modifier gene for the phenotypic expression of the deafness-associated 12S rRNA mutations. Biochem Biophys Res Commun. 2006;342:1130-6.

21. Guan MX, Yan Q, Li X, Bykhovskaya Y, Gallo-Teran J, Hajek P et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet. 2006;79:291-302.

22. Sturman JA, Gaull G, Raiha NC. Absence of cystathionase in human fetal liver: is cystine essential? Science. 1970;169:74-6.

23. Schara U, von Kleist-Retzow JC, Lainka E, Gerner P, Pyle A, Smith PM et al. Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis. 2011;34:197-201.

24. Uusimaa J, Jungbluth H, Fratter C, Crisponi G, Feng L, Zeviani M et al. Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease. J Med Genet. 2011;48:660-668.

25. Gaignard P, Gonzales E, Ackermann O, Labrune P, Correia I, Therond P, Jacquemin E, Slama A. Mitochondrial Infantile Liver Disease due to TRMU Gene Mutations: Three New Cases. JIMD Rep. 2013;11:117-23.